How Insider Trading Disclosure Rules Help Individual Investors
Every public company has a small group of people who understand it better than the market ever will. Officers, directors, and anyone holding more than 10% of the stock see the order book, the pipeline, and the internal forecasts every day. Under Section 16 of the Securities Exchange Act, those same people have to report every trade they make in their own company's stock, and since Sarbanes-Oxley passed in 2002, the deadline has been two business days.
Those reports land on SEC Forms 3, 4, and 5, and all of them are free on EDGAR. Most retail investors never look at this data, and plenty of professionals only glance at it. That has always struck me as odd, because the filings are structured, they arrive quickly, and they tell you what the best-informed people in the building are doing with their own money.
The three forms, and which one to watch
Form 3 is the opening snapshot. When someone becomes an officer, director, or 10% owner, they have ten days to file one disclosing everything they already hold.
Form 4 is the one you care about. Every purchase, sale, option exercise, or stock grant has to be reported here within two business days of the transaction. It wasn't always this fast. Before 2002, insiders had until the tenth day of the following month, so a trade could stay quiet for close to six weeks. Sarbanes-Oxley cut that to two business days, and that change is what turned Form 4 from a historical record into a usable signal.
Form 5 is the annual cleanup, due within 45 days of fiscal year end. It catches small exempt transactions and anything that should have gone on a Form 4 but got missed. Worth a skim once a year, though nearly everything that matters shows up on Form 4 first.
Why buying tells you more than selling
Insiders sell for a hundred reasons. Diversification, a divorce, a down payment, taxes on vested stock. A sale on its own tells you very little because the motivations are so mixed.
Buying is different. An executive already has enormous exposure to the company through salary, bonus, and equity grants. When that person moves personal cash into more shares at the open market price, the only plausible reason is that they expect the stock to be worth more later. Nobody voluntarily concentrates risk they're already loaded with unless they like the price.
The academic work lines up with that intuition. Lakonishok and Lee published a large study of insider trades in 2001 and found that purchases predicted returns while sales carried little information, with the effect strongest in smaller companies. Jeng, Metrick, and Zeckhauser reached a similar conclusion a couple of years later, with portfolios mimicking insider purchases earning abnormal returns while portfolios mimicking sales did not. The measured edge varies by study and by period, so I won't quote a single number, but the asymmetry itself is one of the more consistent findings in the literature. Watch the buys and heavily discount the sells.
What a meaningful purchase looks like
Not every Form 4 with a buy on it means something. A few filters do most of the work.
Open market purchases. Look at the transaction code on the form itself. Code P is an open market or private purchase made with the insider's own money, and it's the only code that represents a voluntary decision to buy at the current price. Grants show up as code A, option exercises as M, sales as S.
Cluster buying. One director buying might be idiosyncratic. Three insiders buying within the same month is a pattern. People with different seats and different views of the business all reached the same conclusion at the same price, and that agreement is informative.
Size relative to pay and holdings. Say a CEO earning $10 million a year buys $50,000 of stock. That's a nice gesture and a weak signal. The same CEO putting in $2 million is telling you something. You can pull total compensation from the proxy statement (the DEF 14A) to make the comparison concrete, and the Form 4 itself shows holdings before and after the trade.
A break from habit. Some insiders trade constantly, and their activity means little. When someone who hasn't touched their position in years suddenly files a large purchase, that departure from routine carries more information than the same trade from a frequent trader.
What to ignore
A lot of Form 4 traffic is administrative. Screen these out before you read anything into a filing.
- 10b5-1 plan transactions. These are pre-scheduled trades the insider committed to months in advance, so the execution date says nothing about what they know today. The SEC's 2022 rule amendments added a checkbox to Form 4 flagging plan trades, which makes them easy to filter.
- Option exercises followed by immediate sales. This is equity compensation being converted to cash on a schedule driven by vesting and expiration dates. It's usually a liquidity decision, and it says little about where the insider thinks the stock is going.
- Gifts, transfers, and tax withholding. Codes G and F. Estate planning and shares withheld for taxes show up on Form 4 but carry no directional view.
Where to get the data and how to watch it
EDGAR is the primary source. Every Form 4 is public the moment it's accepted, filings are indexed by company CIK and by each insider's personal CIK, and the documents come as structured XML, so they're easy to parse programmatically. EDGAR also offers RSS feeds per company, which is the simplest free way to get notified.
Checking filings by hand across a whole portfolio gets old fast, so a little automation helps. A workable monitoring setup has five parts.
- Pull new Form 4 filings daily for your portfolio and watchlist companies, straight from the EDGAR feeds.
- Keep only voluntary open market purchases, meaning code P with no 10b5-1 checkbox.
- Flag clusters, meaning two or more distinct insiders buying within roughly 30 days of each other.
- Score each purchase against the insider's compensation and existing holdings rather than by raw dollars.
- Compare current activity to that company's own history, because unusual behavior only stands out once you know what normal looks like.
You can wire this up with a small script in an evening, or let a platform do it. FirmAdapt's company reports pull Form 4 data straight from EDGAR and surface these patterns alongside the rest of the diagnostic, which saves you the plumbing.
Reading purchases in context
The purchases worth the most attention happen when everyone else is heading the other way. Say a stock has dropped 30% after a rough quarter, and the following week the CEO files a Form 4 showing a seven-figure open market buy. The person with the best view of the business just disagreed with the market at a specific price, in public, with their own money. That doesn't make them right, but it's a data point you can't get anywhere else.
Buying after bad news is a similar setup. Insiders who step in after an earnings miss, a recall, or a regulatory action are usually signaling that they see the damage as temporary. Their read on internal operations is better than anything available from outside, even when their judgment ends up wrong.
Selling works the other way, and more weakly. A single sale is close to meaningless, but heavy selling near all-time highs, from multiple insiders at once and outside any 10b5-1 plan, is worth noting alongside whatever your valuation work says.
Caveats, and where the legal line sits
Insiders are better informed and still frequently wrong. A CEO who buys ahead of a product launch believes the launch will work, and belief is all it is. Treat insider buying as one piece of evidence to weigh, never as an answer key.
Timing is the other problem. Insiders tend to be early. One might see value at $50, buy, and then watch the stock trade down to $40 before it eventually recovers to $70. If you follow the trade, you inherit the drawdown too, so you need the same patience they have. And you're always at least two business days behind the transaction itself, which can matter in fast-moving situations.
On legality, since this confuses people, trading on a filed Form 4 is trading on public information, which is exactly what the disclosure regime was designed to enable. The illegal version is acting on material non-public information, for example a tip from an insider before the form is filed. Once it's on EDGAR, anyone can read it and act on it. One related rule worth knowing about is Section 16(b), the short-swing rule, which forces insiders to hand back profits on round trips completed within six months. It's part of why insider purchases tend to reflect longer holding horizons.
Where this fits in your process
Individuals have a real structural advantage here. An institution that spots a compelling insider cluster still has to clear compliance, size the position, and work the order. You can see a meaningful purchase on Tuesday and own shares on Wednesday. The signal is also strongest in exactly the corner of the market institutions cover least, smaller companies with thin analyst coverage, which matches what Lakonishok and Lee found about small caps.
The best use of the data is confirmation rather than discovery. If your fundamental work says a company is undervalued, the Piotroski F-Score looks healthy, the Beneish M-Score shows no earnings-manipulation flags, and then three insiders buy in the same month, each piece independently supports the same thesis. That layered approach is how we use insider patterns at FirmAdapt, stacked on top of the forensic scores rather than standing alone.
Either way, the filings are free, they're structured, and they arrive within two business days of every trade. Set up feeds for the ten or twenty companies you actually care about, filter down to code P purchases, and check them as they come in. It takes an evening to set up and costs nothing after that.